Age-related changes in adenosine-mediated relaxation of coronary and aortic smooth muscle

Am J Physiol Heart Circ Physiol. 2001 May;280(5):H2380-9. doi: 10.1152/ajpheart.2001.280.5.H2380.

Abstract

We tested whether adenosine mediates nitric oxide (NO)-dependent and NO-independent dilation in coronary and aortic smooth muscle and whether age selectively impairs NO-dependent adenosine relaxation. Responses to adenosine and the relatively nonselective analog 5'-N-ethylcarboxamidoadenosine (NECA) were studied in coronary vessels and aortas from immature (1-2 mo), mature (3-4 mo), and moderately aged (12-18 mo) Wistar and Sprague-Dawley rats. Adenosine and NECA induced biphasic concentration-dependent coronary vasodilation, with data supporting high-sensitivity (pEC(50) = 5.2-5.8) and low-sensitivity (pEC(50) = 2.3-2.4) adenosine sites. Although sensitivity to adenosine and NECA was unaltered by age, response magnitude declined significantly. Treatment with 50 microM N(G)-nitro-L-arginine methyl ester (L-NAME) markedly inhibited the high-sensitivity site, although response magnitude still declined with age. Aortic sensitivity to adenosine declined with age (pEC(50) = 4.7 +/- 0.2, 3.5 +/- 0.2, and 2.9 +/- 0.1 in immature, mature, and moderately aged aortas, respectively), and the adenosine receptor transduction maximum also decreased (16.1 +/- 0.8, 12.9 +/- 0.7, and 9.6 +/- 0.7 mN/mm(2) in immature, mature, and moderately aged aortas, respectively). L-NAME decreased aortic sensitivity to adenosine in immature and mature tissues but was ineffective in the moderately aged aorta. Data collectively indicate that 1) adenosine mediates NO-dependent and NO-independent coronary and aortic relaxation, 2) maturation and aging reduce NO-independent and NO-dependent adenosine responses, and 3) the age-related decline in aortic response also involves a reduction in the adenosine receptor transduction maximum.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Adenosine / pharmacology
  • Adenosine-5'-(N-ethylcarboxamide) / pharmacology
  • Aging / physiology*
  • Animals
  • Aorta / physiology*
  • Coronary Circulation / drug effects
  • Coronary Circulation / physiology
  • Coronary Vessels / physiology*
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiology
  • Enzyme Inhibitors / pharmacology
  • In Vitro Techniques
  • Male
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology*
  • Myocardial Contraction / physiology
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / physiology
  • Nitroprusside / pharmacology
  • Potassium Chloride / pharmacology
  • Rats
  • Rats, Wistar
  • Receptors, Purinergic P1 / physiology
  • Signal Transduction / physiology
  • Vasodilation / drug effects
  • Vasodilation / physiology*
  • Vasodilator Agents / pharmacology

Substances

  • Enzyme Inhibitors
  • Receptors, Purinergic P1
  • Vasodilator Agents
  • Nitroprusside
  • Nitric Oxide
  • Adenosine-5'-(N-ethylcarboxamide)
  • Potassium Chloride
  • Adenosine
  • Acetylcholine
  • NG-Nitroarginine Methyl Ester